688617 惠泰医疗
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)7.08229.09320.21918.57727.354
总资产报酬率 ROA (%)5.41022.25216.89115.98319.270
投入资产回报率 ROIC (%)6.73427.32619.24217.49922.075

边际利润分析
销售毛利率 (%)72.01571.26671.20469.48970.355
营业利润率 (%)34.69736.38432.64726.85024.914
息税前利润/营业总收入 (%)34.09035.94232.27326.81325.325
净利润/营业总收入 (%)30.27731.64027.97323.51321.733

收益指标分析
经营活动净收益/利润总额(%)93.10589.58394.16481.42986.718
价值变动净收益/利润总额(%)2.6923.8795.33814.814-0.056
营业外收支净额/利润总额(%)-0.192-0.679-0.470-0.4281.459

偿债能力分析
流动比率 (X)3.4262.9863.7817.9843.201
速动比率 (X)2.7082.4282.9616.6311.874
资产负债率 (%)19.35923.74619.53811.02923.547
带息债务/全部投入资本 (%)2.1955.7414.1053.4839.721
股东权益/带息债务 (%)4,417.5731,622.8042,308.0372,744.078917.478
股东权益/负债合计 (%)406.143312.144405.440800.893332.088
利息保障倍数 (X)-63.026-182.126-145.934346.318603.103

营运能力分析
应收账款周转天数 (天)8.2859.66112.01416.88434.083
存货周转天数 (天)239.299252.775309.035290.825364.881